- Home
- PRME vs EIKN Comparison
PRME vs EIKN Comparison
Compare PRME & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.42
N/A
Current Price
$9.14
Company Overview
Basic Information| Metric | PRME | EIKN |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 731.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRME | EIKN |
|---|---|---|
| Price | $3.42 | $9.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $7.56 | ★ $25.60 |
| AVG Volume (30 Days) | ★ 2.1M | 341.2K |
| Earning Date | 05-07-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | N/A |
| Revenue This Year | $12.41 | N/A |
| Revenue Next Year | $52.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.11 | $8.65 |
| 52 Week High | $6.94 | $16.50 |
Technical Indicators
Market Signals| Indicator | PRME | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 36.43 |
| Support Level | $3.17 | N/A |
| Resistance Level | $3.94 | $16.34 |
| Average True Range (ATR) | 0.25 | 0.94 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 47.17 | 15.16 |
Price Performance
Historical Comparison PRME
EIKN
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.